ArticleTherapeutic advances in gastroenterology2012

Trastuzumab: a novel standard option for patients with HER-2-positive advanced gastric or gastro-oesophageal junction cancer.

Alicia F C Okines et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.